For years, one question has held Australians back from getting a predictive genetic test: will this affect my insurance? From 8 October 2026, Australian law will permanently remove that barrier. Life insurers will no longer be able to use a predictive genetic test result to refuse cover, raise premiums, or add exclusions to a life insurance policy.
It's a fair concern to have had. Anyone weighing up whether to understand their inherited health risks has had a real reason to hesitate, worried that a high-risk result could mean a higher premium or a declined application for life insurance, income protection or trauma cover. From 8 October, that reason no longer applies.
What the New Law Will Change
The Treasury Laws Amendment (Genetic Testing Protections in Life Insurance and Other Measures) Act 2026 will prohibit life insurers from using adverse predictive genetic test results when assessing an application. In practice, that means:
- Broad coverage. The ban will apply across core life insurance products, including death cover, total and permanent disability (TPD), trauma and income protection.
- Applies going forward. It will cover life insurance decisions made on or after 8 October 2026, including new applications, renewals, variations and increases in cover.
- A permanent, legally binding standard. The Act will replace the voluntary industry moratorium that has applied since 2019, and will remove the financial limit thresholds that moratorium was built around. There will be a single rule across the industry, rather than a voluntary limit insurers could apply differently.
What Insurers Can Still Assess
The new law is specific about what it protects. Standard underwriting will still apply to everything else:
- Individual risk factors. Insurers will still be able to weigh up age, occupation, personal medical history, diagnosed conditions, current symptoms and family history.
- Favourable results can still help your application. If a condition runs in your family and a genetic test shows you don't carry that variant, you'll still be able to choose to voluntarily share that result to support your application.
- Private health insurance is unaffected. Private health insurance in Australia is community-rated. Eligibility and premiums have never been tied to individual health metrics or genetic results, and that isn't changing.
Predictive Results vs a Clinical Diagnosis
The boundary of what will be protected matters. A predictive result, a positive finding for a gene variant when there are currently no symptoms or diagnosed illness, is what the new law will protect. Insurers will not be able to ask for it or use it.
A clinical diagnosis is different. If a doctor has already formally diagnosed an active condition or symptom, insurers will still be able to assess that as part of standard medical history, even if a genetic test helped reach that diagnosis.
Why This Matters for Proactive Healthcare
Genetic testing is most useful before symptoms appear. Finding a genetic variant linked to an inherited cancer syndrome or a cardiovascular condition such as familial hypercholesterolaemia gives a person and their doctor years of lead time, time to plan specialised screening, lifestyle changes or early clinical review, well before anything shows up on a routine test. Once the insurance question is removed, that decision can be made on health grounds alone.
Clinical DNA Testing vs Wellbeing DNA Testing
If you've previously done an i-screen DNA test, it most likely focused on lifestyle factors, how your genes relate to nutrition, fitness, sleep and stress response. That kind of test doesn't screen for inherited disease risk.
Clinical genetic tests are a different category. They're built specifically to identify actionable, inherited disease risks, the kind a person and their doctor can act on.
i-screen's Clinical Genetic Tests
| Test Name | Price | Genes Screened | Primary Focus Area |
|---|---|---|---|
| Hereditary Disease Risk Test | $1,350 | 184 genes | Comprehensive panel covering both inherited cancers and cardiovascular conditions, where early detection changes clinical care. |
| Cancer Risk Test | $1,099 | 69 genes | Focused panel for inherited cancers, including hereditary breast, ovarian, colorectal and prostate cancer risk. |
| Cardiac Disease Risk Test | $1,099 | 88 genes | Focused panel covering familial hypercholesterolaemia, cardiomyopathies, heart rhythm disorders, aortic disease and clotting risk. |
All three use an at-home saliva sample. A NATA-accredited laboratory analyses it, with results typically available in 4 to 6 weeks.
Accredited Genetic Counselling Is Included
Inherited health risks don't stop with the person tested, they can matter for children, siblings and parents too. Every clinical genetic test ordered through i-screen includes a one-on-one telehealth consultation with an accredited genetic counsellor as standard. They walk you through your results, what they mean for you and your family, and the next steps to discuss with your doctor. For how i-screen stores and protects genetic data, see the Hereditary Disease Risk Test page.
Is Clinical DNA Testing Right for You?
Most people don't carry a high-risk pathogenic variant. Clinical testing tends to be most useful where:
- A serious condition runs in the family.
- Close relatives were diagnosed with cancer or heart disease at a young age.
- You want a proactive genetic baseline as part of a personal health strategy.
If you're not sure which panel fits your situation, i-screen's team and network of healthcare professionals can help you work that out, or compare the options on the Genetics & DNA health goal page.
Frequently Asked Questions
What if I already hold an existing life insurance policy? The new law will apply to new applications, renewals, variations and increases in cover made on or after 8 October 2026. An existing, unchanged policy will stay active under its original terms.
If my test identifies a high-risk gene, will I have to call my insurer? No. There will be no obligation to notify an existing insurer about a predictive genetic test result obtained after a policy is already in place.
Will this protection apply in every Australian state and territory? Yes. It's federal legislation administered through the Insurance Contracts Act, so it will apply to life insurance decisions Australia-wide, not just in specific states.
This article is general information, not personal medical, financial or legal advice. It does not diagnose any condition. Always discuss your results with a qualified healthcare professional, and speak with a licensed financial adviser about how the new law applies to your own insurance. i-screen provides wellness and educational services only. Our services do not diagnose, treat, cure, or prevent any disease or medical condition.
